In addition, it was determined that it promoted the growth of BC cells by regulating the KLF9/RGS axis, suggesting that it may be an interesting object of study using patient-derived biological material to analyse its potential use as a diagnostic biomarker or therapeutic target in BC [113]. This evidence concerns the gene PITX2 and breast cancer.